Zonisamide suppresses pain symptoms of formalin-induced inflammatory and streptozotocin-induced diabetic neuropathy

Journal of Pharmacological Sciences

Volumn 107, Issue 2, 2008, Pages 213-220

  Tanabe, Mitsuo ^a   Murakami, Takuhiro ^a   Ono, Hideki ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Diabetes; Formalin; Inflammatory pain; Neuropathic pain; Zonisamide

Indexed keywords

FORMALDEHYDE; STREPTOZOCIN; ZONISAMIDE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG MECHANISM; INFLAMMATORY PAIN; LICKING; MALE; MECHANICAL STIMULATION; MOUSE; NERVE EXCITABILITY; NEUROPATHIC PAIN; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; SPINAL CORD DORSAL HORN; WITHDRAWAL REFLEX;

EID: 46449122432     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08032FP     Document Type: Article

References (41)

1. Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 1988;33:11-23.
2. Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nature Medicine. 2004;10:685-692.
3. Ruscheweyh R, Sandkühler J. Epileptiform activity in rat spinal dorsal horn in vitro has common features with neuropathic pain. Pain. 2003;105:327-338.
4. Hord AH, Denson DD, Chalfoun AG, Azevedo MI. The effect of systemic zonisamide (Zonegran™) on thermal hyperalgesia and mechanical allodynia in rats with an experimental mononeuropathy. Anesth Analg. 2003;96:1700-1706.
5. Tanabe M, Sakaue A, Takasu K, Honda M, Ono H. Centrally mediated antihyperalgesic and antiallodynic effects of zonisamide following partial nerve injury in the mouse. Naunyn Schmiedebergs Arch Pharmacol. 2005;372:107-114.
6. Baulac M. Introduction to zonisamide. Epilepsy Res. 2006;68 Suppl 2:S3-S9.
7. Pappagallo M. Newer antiepileptic drugs: possible uses in the treatment of neuropathic pain and migraine. Clin Ther. 2003;25:2506-2538.
8. Tanabe M, Takeuchi Y, Ono H. The supraspinally mediated analgesic effects of zonisamide in mice after peripheral nerve injury are independent of the descending monoaminergic system. J Pharmacol Sci. 2007;104:335-340.
9. Masuda Y, Ishizaki M, Shimizu M. Zonisamide: pharmacology and clinical efficacy in epilepsy. CNS Drug Rev. 1998;4:341-360.
10. Suzuki S, Kawakami K, Nishimura S, Watanabe Y, Yagi K, Seino M, et al. Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex. Epilepsy Res. 1992;12:21-27.
11. Mori A, Noda Y, Packer L. The anticonvulsant zonisamide scavenges free radicals. Epilepsy Res. 1998;30:153-158.
12. Noda Y, Mori A, Packer L. Zonisamide inhibits nitric oxide synthase activity induced by N-methyl-D-aspartate and buthionine sulfoximine in the rat hippocampus. Res Commun Mol Pathol Pharmacol. 1999;105:23-33.
13. Coderre TJ, Vaccarino AL, Melzack R. Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res. 1990;535:155-158.
14. Khan GM, Chen SR, Pan HL. Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience. 2002;114:291-299.
15. Suzuki Y, Sato J, Kawanishi M, Mizumura K. Lowered response threshold and increased responsiveness to mechanical stimulation of cutaneous nociceptive fibers in streptozotocin-diabetic rat skin in vitro - correlates of mechanical allodynia and hyperalgesia observed in the early stage of diabetes. Neurosci Res. 2002;43:171-178.
16. Chen X, Levine JD. Hyper-responsivity in a subset of C-fiber nociceptors in a model of painful diabetic neuropathy in the rat. Neuroscience. 2001;102:185-192.
17. Dixon WJ. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol. 1980;20:441-462.
18. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53:55-63.
19. Haley TJ, McCormick WG. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother. 1957;12:12-15.
20. Hylden JL, Wilcox GL. Intrathecal morphine in mice: a new technique. Eur J Pharmacol. 1980;67:313-316.
21. Glantz SA. Alternatives to analysis of variance and the t test based on ranks. In: Jeffers JD, Englis MR, editors. Primer of Biostatistics. 3rd ed. New York: McGraw-Hill; 1992. p. 320-371.
22. Masuda Y, Utsui Y, Shiraishi Y, Karasawa T, Yoshida K, Shimizu M. Relationships between plasma concentrations of diphenylhydantoin, phenobarbital, carbamazepine, and 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810), a new anticonvulsant agent, and their anticonvulsant or neurotoxic effects in experimental animals. Epilepsia. 1979;2:623-633.
23. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765-1769.
24. Yang L, Zhang FX, Huang F, Lu YJ, Li GD, Bao L, et al. Peripheral nerve injury induces trans-synaptic modification of channels, receptors and signal pathways in rat dorsal spinal cord. Eur J Neurosci. 2004;19:871-883.
25. Yashpal K, Fisher K, Chabot JG, Coderre TJ. Differential effects of NMDA and group I mGluR antagonists on both nociception and spinal cord protein kinase C translocation in the formalin test and a model of neuropathic pain in rats. Pain. 2001;94:17-29.
26. Coderre TJ, Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci. 1992;12:3665-3670.
27. Yamamoto T, Yaksh TL. Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology. 1992;77:757-763.
28. Yashpal K, Mason P, McKenna JE, Sharma SK, Henry JL, Coderre TJ. Comparison of the effects of treatment with intrathecal lidocaine given before and after formalin on both nociception and Fos expression in the spinal cord dorsal horn. Anesthesiology. 1998;88:157-164.
29. Yamamoto T, Yaksh TL. Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists. Pain. 1992;49:121-128.
30. Chaplan SR, Malmberg AB, Yaksh TL. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther. 1997;280:829-838.
31. Erichsen HK, Blackburn-Munro G. Pharmacological characterisation of the spared nerve injury model of neuropathic pain. Pain. 2002;98:151-161.
32. Ma W, Du W, Eisenach JC. Intrathecal lidocaine reverses tactile allodynia caused by nerve injuries and potentiates the anti-allodynic effect of the COX inhibitor ketorolac. Anesthesiology. 2003;98:203-208.
33. Wei H, Pertovaara A. Influence of preemptive treatment with MK-801, an N-methyl-D-aspartate receptor antagonist, on development of neuropathic symptoms induced by spinal nerve ligation in the rat. Anesthesiology. 1999;91:313-316.
34. Dahl JB, Brennum J, Arendt-Nielsen L, Jensen TS, Kehlet H. The effect of pre-versus postinjury infiltration with lidocaine on thermal and mechanical hyperalgesia after heat injury to the skin. Pain. 1993;53:43-51.
35. Carlton SM, Zhou S. Attenuation of formalin-induced nociceptive behaviors following local peripheral injection of gabapentin. Pain. 1998;76:201-207.
36. Sakaue A, Honda M, Tanabe M, Ono H. Antinociceptive effects of sodium channel-blocking agents on acute pain in mice. J Pharmacol Sci. 2004;95:181-188.
37. + channel blockers in the formalin test. Eur J Pharmacol. 2002;445:231-238.
38. Hong S, Morrow TJ, Paulson PE, Isom LL, Wiley JW. Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J Biol Chem. 2004;279:29341-29350.
39. Hong S, Wiley JW. Altered expression and function of sodium channels in large DRG neurons and myelinated A-fibers in early diabetic neuropathy in the rat. Biochem Biophys Res Commun. 2006;339:652-660.
40. Ikeda H, Heinke B, Ruscheweyh R, Sandkühler J. Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science. 2003;299:1237-1240.
41. Cheng JK, Lin CS, Chen CC, Yang JR, Chiou LC. Effects of intrathecal injection of T-type calcium channel blockers in the rat formalin test. Behav Pharmacol. 2007;18:1-8.